Waddill William D.
SEC Form 4 insider trading activity
Waddill William D. has filed 10 SEC Form 4 filings (30 transaction rows) across 2 companies, including PTGX, ARWR, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jun 25, 2026.
On the most recent filing, Waddill William D. is listed as Director at Protagonist Therapeutics, Inc. Inside the rolling window, Waddill William D. reported no open-market purchases and 7 open-market sales totaling $6.4M in PTGX and ARWR. The largest disclosed transaction in the window is a sale of 20,000 PTGX shares on Feb 6, 2026, worth $1.7M.
Companies traded
Other insiders at PTGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.4M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 27, 2025 | PTGX | Sale | $237K |
Frequently asked questions
How many SEC Form 4 filings has Waddill William D. made?
Waddill William D. has filed 10 SEC Form 4 filings (30 transaction rows) across 2 companies, including PTGX, ARWR since 2025.
Which companies does Waddill William D. trade?
Waddill William D. has filed SEC Form 4 disclosures for 2 companies, including PTGX, ARWR.
When was Waddill William D.'s most recent SEC Form 4 filing?
Waddill William D.'s most recent SEC Form 4 filing on Tracefour is dated Jun 25, 2026.
What is Waddill William D.'s total buy and sell value in the current window?
Inside the rolling retention window, Waddill William D. bought $0 and sold $6.4M based on SEC Form 4 filings.
What was Waddill William D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 PTGX shares on 2026-02-06, worth $1.7M, per SEC Form 4 filings.